Myqorzo and Redemplo approved in ChinaApproval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia ...

Myqorzo and Redemplo approved in China Approval of Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndromeUnderscores Sanofi's long-term commitment to ...

A human heart might contract some three billion times over a lifetime, and each one of those contractions is driven by a protein called myosin. One of three classes of so-called motor proteins in our ...

Salt stress is a major factor that impairs plant growth and yield. In a breakthrough, researchers from Waseda University have revealed that Arabidopsis thaliana myosin XI-1—a member of the motor ...

PATIENTS BATTLING ONE OF THE DEADLIEST FORMS OF BRAIN CANCER GLIOBLASTOMA. SCIENTISTS IN JUPITER AT THE WERTHEIM UF SCRIPPS INSTITUTE ARE BEHIND A GROUNDBREAKING DISCOVERY. THEY HAVE DEVELOPED A FIRST ...

A new R01 grant from the National Institutes of Health (NIH) awarded to the Department of Molecular Physiology and Biophysics is helping University of Vermont researchers reshape how scientists ...

Researchers have cracked the code behind how plants make mitraphylline, a rare cancer-fighting molecule. Their discovery of two critical enzymes explains how nature builds complex spiro-shaped ...

GAINESVILLE, Fla. (WCJB) - In this week’s Tech Tuesday, our partners at UF Innovate and SCAD Media highlight Myosin Therapeutics, a biomedical company developing myosin inhibitors to treat cancer. Dr.

This manuscript describes a novel method for determining the mechanical parameters of the kinesin, KIF1A, that uses fluorescence microscopy and does not require an optical tweezer apparatus. The ...

Depression and anxiety disorders are among the most widespread mental health disorders, with estimates suggesting that they affect around 264 million and 284 million people worldwide, respectively.

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs ...